AZITHROMYCIN (AZITHROMYCIN) — FDA Approval NDA050809 (TEVA PARENTERAL)
AZITHROMYCIN (AZITHROMYCIN) — FDA Approval NDA050809 (TEVA PARENTERAL) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: AZITHROMYCIN; Active ingredients: AZITHROMYCIN; Application number: NDA050809.
| Brand name | AZITHROMYCIN |
|---|---|
| Active ingredients | AZITHROMYCIN |
| Application number | NDA050809 |
| Sponsor | TEVA PARENTERAL |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20061219 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →